Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Welcome to the February issue! The elderly are the central focus of our cover feature as we ask how pharma can better meet the diverse needs of older patients. Meanwhile in Upfront, we present an infographic snapshot of drug development in Europe, and researchers also enlighten us about the therapeutic potential of nanoparticles. In Business, George Chressanthis argues that the CVS-Aetna merger will prove a transformative event for pharma, while James Strachan explores the consequences of a “no-deal” Brexit for the drug development industry. We also Sit Down With Steve Arlington, who is facilitating collaborations as President at the Pistoia Alliance.